Amanta Healthcare IPO Listing at 7.14% Premium at ₹135 Per Share

Posted by : sachet | Tue Sep 09 2025

Check Experts’ Verdicts on Amanta Healthcare Limited

Amanta Healthcare IPO Listing: The Amanta Healthcare IPO was subscribed 82.60 times as of its closing. In this subscription, qualified institutional buyers (QIBs) received 35.86 times the allocation, and non-institutional investors (NIIs) received 209.40 times the allocation. The retail quota of the issue was subscribed to 35.00%. Before delving deeper into the topic, go through the details of the Amanta Healthcare IPO.

Table of Contents

Amanta Healthcare IPO Listing

On the NSE (National Stock Exchange), Shares are listed at ₹135 per share, reflecting the premium of 7.14% against the issue price of ₹126 per share. On the other hand, BSE (Bombay Stock Exchange shares are listed at ₹134 per share, reflecting the premium of 6.35%.

Amanta Healthcare IPO Details

Amanta Healthcare IPO is open for bidding from 1st September 2025 to 3rd September 2025. It is a bookbuilding IPO of ₹126.00 crore, comprising a fresh issue of 1.00 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 9th September 2025. The Amanta Healthcare IPO date is fixed between 1st September 2025 and 3rd September 2025. The face value of Amanta Healthcare IPO shares is ₹10 per share, and the IPO price is set at ₹120.00 to ₹126.00 per share.

IPO Open Date	1st September 2025
IPO Close Date	3rd September 2025
IPO Allotment Date	4th September 2025
Refund Initiation	8th September 2025
Issue Size	1,00,00,000 shares(aggregating up to ₹126.00 Cr)
Face Value	₹10 per share
Lot Size	119 shares
Issue Price Band	₹120.00 to ₹126.00 per share
Issue Type	Bookbuilding IPO
Listing At	BSE & SME
Listing Date	9th September 2025

About Amanta Healthcare Limited

Amanta Healthcare Limited was established in December 1994. Amanta Healthcare Limited is a pharmaceutical company that specialises in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilising Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.

The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.

Amanta Healthcare Limited Financials

The company’s financial analysis is essential before applying for the Amanta Healthcare IPO. Look at the table to learn about Amanta Healthcare Limited’s financials.

Year Ended	31st March 2025 (in cr.)	31st March 2024 (in cr.)	31st March 2023 (in cr.)
Assets	381.76	352.12	374.06
Revenue	276.09	281.61	262.70
Profit After ax	10.50	3.63	-2.11
EBITDA	61.05	58.76	56.31
Net Worth	96.39	66.29	62.88
Reserve and surplus	67.56	39.46	36.05
Total Borrowing	195.00	205.23	215.66

Explanation

Amanta Healthcare Limited’s revenue increased by 2% from ₹281.61 crores in March 2024 to ₹276.09 crores in March 2025. Moreover, the company’s PAT rose by 189% from ₹3.63 crores to ₹10.50 crores.